What does Behçet’s disease in women mean?

Behçet’s disease in women refers to a chronic, systemic autoimmune disorder that affects multiple organ systems and is characterized by recurrent oral and genital ulcers, uveitis, and skin lesions. While Behçet’s disease occurs in both sexes, it tends to present with distinct clinical patterns in women—often with milder systemic involvement but higher frequencies of mucocutaneous manifestations, such as oral aphthae and erythema nodosum. Women may also experience more frequent gastrointestinal involvement and are at increased risk for thrombosis, particularly deep vein thrombosis and cerebral venous sinus thrombosis, due to the prothrombotic state associated with the disease. Importantly, hormonal fluctuations—including those during menstruation, pregnancy, or contraceptive use—can influence disease activity, though evidence on estrogen’s role remains complex and not fully elucidated. Diagnosis relies on clinical criteria (e.g., the International Criteria for Behçet’s Disease), as no single definitive laboratory test exists. Management involves immunomodulatory therapy tailored to organ involvement—common agents include colchicine for mucocutaneous disease, corticosteroids for acute flares, and biologics such as anti-TNFα agents (e.g., infliximab, adalimumab) for severe or refractory cases. Close multidisciplinary follow-up—including rheumatology, ophthalmology, dermatology, and gynecology—is essential for optimizing long-term outcomes.